The Global Artificial Intelligence (AI) in
Pharmaceutical Market is driven by increasing demand for personalized medicine

The Global Artificial Intelligence
(AI) in Pharmaceutical Market includes technologies that use AI and machine
learning for drug discovery and various clinical processes. AI tools help
analyze large amounts of data to discover new biological targets, design
protein structures, and identify potentially unsafe drug reactions and side
effects. Various AI techniques like deep learning, machine learning, and
natural language processing are applied at different stages of drug development
for tasks like improving clinical trial recruitment and monitoring. AI provides
pharmaceutical companies with capabilities to develop drugs faster and more
efficiently. It personalizes treatment strategies based on individual patient
profiles and speeds up molecular simulation and genetic research for precision
medicine.



The Global artificial intelligence (AI)
in pharmaceutical market is estimated to be valued at USD 1,108.1 Mn in 2024
and is expected to reach USD 7,776.2 Mn by 2031, exhibiting a compound annual
growth rate (CAGR) of 32.1% from 2024 to 2031.

Personalized treatments tailored to
an individual's genetic profile are driving the need for AI-powered drug
discovery and development. AI techniques are able to analyze massive volumes of
genomic and clinical datasets to identify new treatments. This is fueling
demand and enabling the market's rapid growth.



Key Takeaways



Key players operating in the Global Artificial Intelligence (AI) in
Pharmaceutical Market are NVIDIA Corporation, IBM Corporation, Exscientia,
Insilico Medicine, Atomwise, Inc., Cloud Pharmaceuticals, Inc., Cyclica Inc.,
Envisagenics, Inc., Numerate, Inc., Schrödinger, Inc., Standigm, Turbine.ai,
BenevolentAI, Recursion Pharmaceuticals, Owkin, Inc., XtalPi Inc., Valo Health,
Absci. These players are increasing investments in AI technologies and
partnering with pharmaceutical companies and research organizations to develop
new algorithms and platforms.



The Global
Artificial Intelligence (AI) In Pharmaceutical Market Demand AI tools
can analyze patient's genetic and health records to design custom-made
treatment plans. They also help develop drugs for rare conditions by
identifying biological patterns and new molecular targets based on limited
clinical datasets. This expanding role in precision medicine is fueling revenue
growth.



AI is enabling pharmaceutical companies to expand into new geographical
markets. Tools that expedite drug discovery and clinical research allow
companies to address unmet medical needs across global populations quicker and
at lower costs. Many leading players are partnering with Asian and African
countries to develop and commercialize new therapies using AI techniques. This
increasing focus on international expansion is expected to drive the market in
the coming years.



Market Drivers



The increasing demand for personalized medicine Global
Artificial Intelligence (AI) In Pharmaceutical Market Size And Trends AI's
ability to integrate diverse data sources help enhance drug efficacy for
individuals. Pharmaceutical firms are collaborating with AI companies to
develop new algorithms incorporating multi-omics data, real-world evidence, and
electronic health records. This helps design targeted therapies, monitor
treatment response, and optimize drug regimens. The promise of precision
medicine through AI is revolutionizing healthcare and accelerating market
growth.

Get
More Insights On, Global
Artificial Intelligence (AI) In Pharmaceutical Market